Cochlear Secures U.S. Duty-Free Access
Cochlear said its hearing implant systems will continue to enter the United States duty-free after the final Section 301 review, preserving cost-free access for American patients relying on the devices. The company highlighted a large unmet clinical need with only about 5% of those who could benefit currently receiving implants, and plans to engage regulators and policy makers to expand access worldwide.